Brown, Lisle/Cummings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.4K | Hold |
75
| – | – | 0.01% | 362 |
|
|
2025
Q1 | $47.6K | Hold |
75
| – | – | 0.01% | 334 |
|
|
2024
Q4 | $53.4K | Buy |
75
+10
| +15% | +$7.12K | 0.02% | 328 |
|
|
2024
Q3 | $68.3K | Hold |
65
| – | – | 0.02% | 292 |
|
|
2024
Q2 | $68.3K | Buy |
65
+10
| +18% | +$10.5K | 0.02% | 284 |
|
|
2024
Q1 | $52.9K | Hold |
55
| – | – | 0.02% | 287 |
|
|
2023
Q4 | $48.3K | Hold |
55
| – | – | 0.02% | 288 |
|
|
2023
Q3 | $45.3K | Sell |
55
-20
| -27% | -$16.5K | 0.02% | 278 |
|
|
2023
Q2 | $53.9K | Hold |
75
| – | – | 0.02% | 270 |
|
|
2023
Q1 | $61.6K | Hold |
75
| – | – | 0.03% | 260 |
|
|
2022
Q4 | $54.1K | Hold |
75
| – | – | 0.03% | 257 |
|
|
2022
Q3 | $51.7K | Hold |
75
| – | – | 0.03% | 249 |
|
|
2022
Q2 | $44.3K | Hold |
75
| – | – | 0.02% | 270 |
|
|
2022
Q1 | $52.4K | Hold |
75
| – | – | 0.03% | 262 |
|
|
2021
Q4 | $47.4K | Buy |
+75
| New | +$47.4K | 0.02% | 267 |
|